Thymidine phosphorylase mutations cause instability of mitochondrial DNA

被引:42
作者
Hirano, M
Lagier-Tourenne, C
Valentino, ML
Martí, R
Nishigaki, Y
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA
[2] Hosp Univ Vall Hebron, Ctr Invest Bioquim & Biol Mol, Barcelona, Spain
[3] Natl Inst Neurosci, Dept Neuromuscular Res, Natl Ctr Neurol & Psychiat, Tokyo, Japan
关键词
mitochondrial DNA; thymidine phosphorylase; MNGIE; nucleoside; nucleotide;
D O I
10.1016/j.gene.2005.04.041
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder characterized by ptosis and progressive external ophthalmoplegia, peripheral neuropathy, severe gastrointestinal dysmotility, cachexia and leukoencephalopathy. Muscle biopsies of MNGIE patients have revealed morphologically abnormal mitochondria and defects of respiratory chain enzymes. In addition, patients harbor depletion, multiple deletions, and point mutations of mitochondrial DNA (mtDNA). This disorder is caused by loss-of-function mutations in the gene encoding thymidine phosphorylase (TP) a cytosolic enzyme. In MNGIE patients, TP activity is very low or absent resulting in dramatically elevated levels of plasma thymidine and deoxyuridine. We have hypothesized that the increased levels of thymidine and deoxyuridine cause mitochondrial nucleotide pool imbalances that, in turn, generate mtDNA alterations. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:152 / 156
页数:5
相关论文
共 40 条
[1]
Brown NS, 1998, BIOCHEM J, V334, P1
[2]
BUROKER NE, 1990, GENETICS, V124, P157
[3]
Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses [J].
Carrozzo, R ;
Hirano, M ;
Fromenty, B ;
Casali, C ;
Santorelli, FM ;
Bonilla, E ;
DiMauro, S ;
Schon, EA ;
Miranda, AF .
NEUROLOGY, 1998, 50 (01) :99-106
[4]
Mitochondrial DNA repair pathways [J].
Croteau, DL ;
Stierum, RH ;
Bohr, VA .
MUTATION RESEARCH-DNA REPAIR, 1999, 434 (03) :137-148
[5]
Mechanisms of disease: Mitochondrial respiratory-chain diseases [J].
DiMauro, S ;
Schon, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2656-2668
[6]
FERSHT AR, 1979, P NATL ACAD SCI USA, V76, P4946, DOI 10.1073/pnas.76.10.4946
[7]
Thymidine Phosphorylase: A Two-Face Janus in Anticancer Chemotherapy [J].
Focher, F. ;
Spadari, S. .
CURRENT CANCER DRUG TARGETS, 2001, 1 (02) :141-153
[8]
PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE EXPRESSION IN NORMAL-TISSUES - AN IMMUNOHISTOCHEMICAL STUDY [J].
FOX, SB ;
MOGHADDAM, A ;
WESTWOOD, M ;
TURLEY, H ;
BICKNELL, R ;
GATTER, KC ;
HARRIS, AL .
JOURNAL OF PATHOLOGY, 1995, 176 (02) :183-190
[9]
A novel thymidine phosphorylase mutation in a Spanish MNGIE patient [J].
Gamez, J ;
Lara, MC ;
Mearin, F ;
Oliveras-Ley, C ;
Raguer, N ;
Olive, M ;
Leist, AT ;
Perello, A ;
Perona, M ;
Cervera, C ;
Andreu, AL ;
Martí, R ;
Hirano, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 228 (01) :35-39
[10]
Phenotypic variability in a Spanish family with MNGIE [J].
Gamez, J ;
Ferreiro, C ;
Accarino, ML ;
Guarner, L ;
Tadesse, S ;
Martí, RA ;
Andreu, AL ;
Raguer, N ;
Cervera, C ;
Hirano, M .
NEUROLOGY, 2002, 59 (03) :455-457